DIVERSIFIED HEALTHCARE TRUST
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.54B | $1.50B | $1.41B | $1.28B | $1.38B | $1.63B | $1.04B | $1.12B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $45.5M | $26.5M | $26.1M | $26.4M | $34.1M | $30.6M | $37.0M | $85.9M |
| Operating Income | $-320.9M | $-371.4M | $-80.9M | $188.3M | $437.1M | $68.4M | $97.3M | $471.7M |
| Operating Margin | -20.9% | -24.8% | -5.7% | 14.7% | 31.6% | 4.2% | 9.4% | 42.2% |
| Interest Expense | — | — | $191.8M | $209.4M | $255.8M | $201.5M | $180.1M | $179.3M |
| Pretax Income | $-320.9M | $-371.4M | $-272.7M | $-21.1M | $181.4M | $-133.1M | $-82.8M | $292.4M |
| Income Tax Expense | $1.7M | $467.0K | $445.0K | $710.0K | $1.4M | $1.3M | $436.0K | $476.0K |
| Net Income | $-285.9M | $-370.3M | $-293.6M | $-15.8M | $174.5M | $-139.5M | $-88.2M | $286.9M |
| Net Margin | -18.6% | -24.8% | -20.8% | -1.2% | 12.6% | -8.5% | -8.5% | 25.7% |
| EPS (Basic) | $-1.19 | $-1.55 | $-1.23 | $-0.07 | $0.73 | $-0.59 | $-0.37 | $1.21 |
| EPS (Diluted) | $-1.19 | $-1.55 | $-1.23 | $-0.07 | $0.73 | $-0.59 | $-0.37 | $1.21 |
| Shares Outstanding (Basic) | 240.3M | 239.5M | 238.8M | 238.3M | 238.0M | 237.7M | 237.6M | 237.5M |
| Shares Outstanding (Diluted) | 240.3M | 239.5M | 238.8M | 238.3M | 238.0M | 237.7M | 237.6M | 237.5M |
| Dividends Per Share | $0.04 | $0.04 | $0.04 | $0.04 | $0.04 | $0.18 | $0.84 | $1.56 |